Calcified Tissue International

, Volume 74, Issue 4, pp 322–329 | Cite as

Insulin-Like Growth Factor I Is a Determinant of Hip Bone Mineral Density in Men Less Than 60 years of Age: MINOS Study

  • P. Szulc
  • M. O. Joly–Pharaboz
  • F. Marchand
  • P. D. Delmas
Article

Abstract

Several studies show that in elderly men bone mineral density (BMD) is not correlated with the insulin-like growth factor (IGF-I) level, but data are scanty in young men. Results of studies correlating insulin-like growth factor binding protein 3 (IGFBP-3) and BMD in men are discordant. As different hypotheses can explain the discordant results, we evaluated the correlation of BMD with serum IGF-I, IGFBP-3, and IGF-I/IGFBP-3 index in a large cohort of 721 men aged 19–85 years taking into account age, body weight, 17β-estradiol, free testosterone, and parathyroid hormone. Serum IGF-I and IGFBP-3 decreased with age (r = −0.44 and r = −0.36, P = 0.0001). After adjustment for confounding variables, IGF-I correlated weakly positively with BMD and with bone mineral apparent density (BMAD) of hip as well as with cortical thickness of femoral neck, both of which are determined mainly by bone resorption, but not with bone size determined by periosteal apposition. IGF-I correlated weakly positively with BMD at the whole body and at the third lumbar vertebra IGFBP-3 and IGF-I/IGFBP-3 index did not correlate with densitometric parameters. In men aged 19–60 years, IGF-I correlated with BMD and BMAD of total hip and with cortical thickness of femoral neck positively and more strongly than in the entire cohort but not with the size of proximal femur. BMD of total hip was 6% higher in men in the highest quartile of IGF-I than in men in the lowest quartile. IGF-I, IGFBP-3, and IGF-I/IGFBP-3 index did not correlate with densitometric parameters of other sites. In the men aged more than 60 years, neither IGF-I nor IGFBP-3 nor IGF-I/IGFBP-3 index correlated with BMD, BMAD, or bone size. In men aged 19–60 years, the most significant hormonal determinants of BMD and BMAD of the hip and of the cortical thickness of femoral neck were 17β-estradiol and IGF-I (P < 0.05–0.0001). In men aged more than 60 years, the most significant determinants of hip BMD were 17β-estradiol and PTH. In conclusion, IGF-I seems to contribute to the inhibition of bone resorption and to maintaining bone mass of the proximal femur during the phase of slow bone loss in men aged less than 60 years. IGFBP-3 and IGF-I/IGFBP-3 index were not correlated with BMD or bone size.

Keywords

Male osteoporosis Bone mineral density Insulin-like growth factor I Insulin-like growth factor-binding protein 3 

References

  1. 1.
    Barrett–Connor, E, Goodman–Gruen, D 1998Gender differences in insulin-like growth factor and bone mineral density association in old age: the Rancho Bernardo study.J Bone Miner Res1313431349Google Scholar
  2. 2.
    Langlois, JA, Rosen, CJ, Visser, M, Hannan, MT, Harris, T, Wilson, PWF, Kiel, DP 1998Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study.J Clin Endocrinol Metab8342574262Google Scholar
  3. 3.
    Taaffe, DR, Cooper, CS, Holloway, L, Duret, C, Marcus, R 1999Lack of association of anabolic hormone status and muscle strength with regional and whole body bone mineral density in healthy men aged 60-79 years.Aging Clin Exp Res11411Google Scholar
  4. 4.
    Center, JR, Nguyen, TV, Sambrook, PN, Eisman, JA 1999Hormonal and biochemical parameters in the determination of osteoporosis in elderly men.J Clin Endocrinol Metab8436263635PubMedGoogle Scholar
  5. 5.
    O’Connor, KG, Tobin, JD, Harman, SM, Plato, CC, Roy, TA, Sherman, SS, Blackman, MR 1998.J Gerontol A Biol Sci Med Sci53M176M182Google Scholar
  6. 6.
    Janssen, JAMJL, Burger, H, Stolk, RP, Grobbee, DE, de Jong, FH, Lamberts, SWJ, Pols, HAP 1998Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women.Eur J Endocrinol138627632Google Scholar
  7. 7.
    Martinez Diaz–Guerra, G, Hawkins, F, Rapado, A, Ruiz Diaz, MA, Diaz–Curiel, M 2001Hormonal and anthropometric predictors of bone mass in healthy elderly men: major effect of sex hormone binding globulin, parathyroid hormone and body weight.Osteoporos Int12178184CrossRefPubMedGoogle Scholar
  8. 8.
    Pfeilschifter, J, Scheidt–Nave, C, Leidug–Bruckner, G, Woitge, HW, Blum, WF, Wüster, C, Haack, D, Ziegler, R 1996Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women.J Clin Endocrinol Metab8125342540PubMedGoogle Scholar
  9. 9.
    Rudman, D, Drinka, PJ, Wilson, CR, Mattson, DE, Scherman, F, Cuisinier, MC, Schultz, S 1994Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men.Clin Endocrinol40653661Google Scholar
  10. 10.
    Johansson, AG, Forslund, A, Hambraeus, L, Blum, WF, Ljunghall, S 1994Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.J Bone Miner Res9915921Google Scholar
  11. 11.
    Gillberg, P, Olofsson, H, Mallmin, H, Blum, WF, Ljunghall, S, Nilsson, AG 2002Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF-I) and IGF-binding protein (IGFBP)-3 in Swedish men.Calcif Tissue Int702229CrossRefPubMedGoogle Scholar
  12. 12.
    Ravaglia, G, Forti, P, Maioli, F, Nesi, B, Pratelli, L, Cucinotta, D, Bastagli, L, Cavalli, G 2000Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy men and women.Gerontol A Biol Sci Med Sci55M516M521Google Scholar
  13. 13.
    Ormarsdottir, S, Ljunggren, Ö, Malmin, H, Olofsson, H, Blum, WF, Lööf, L 2001Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density.Liver21123129CrossRefPubMedGoogle Scholar
  14. 14.
    Jorgensen, JOL, Vahl, N, Hansen, TB, Skjaerbaek, C, Fisker, S, Orskov, H, Hagen, C, Christiansen, JS 1998Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects.Clin Endocrinol48479486Google Scholar
  15. 15.
    Rajaram, S, Baylink, DJ, Mohan, S 1997Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and function.Endocrine Rev18801831Google Scholar
  16. 16.
    Janssen, JAMJL, Stolk, RP, Pols, HAP, Grobbee, DE, de Jong, FH, Lamberts, SWJ 1998Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels.Clin Endocrin48471478Google Scholar
  17. 17.
    Benbassat, CA, Maki, KC, Unterman, TG 1997Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, a,d dehydroepiandrosterone sulfate levels and anthropometric measures..8214841491Google Scholar
  18. 18.
    Paolisso, G, Ammendola, S, del Buono, A, Gambardella, A, Riondino, M, Tagliamonte, MR, Rizzo, MR, Carella, C, Varricchio, M 1997Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.J Clin Endocrinol Metab8222042209PubMedGoogle Scholar
  19. 19.
    Johansson, AG, Eriksen, EF, Lindh, E, Langdahl, B, Blum, WF, Lindahl, A, Ljunggren, Ö, Ljunghall, S 1997Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men.J Clin Endocrinol Metab8227952798PubMedGoogle Scholar
  20. 20.
    Szulc, P, Marchand, F, Dubeouf, F, Delmas, PD 2000Cross-sectional assessment of age-related bone loss in men: the MINOS study.Bone26123129CrossRefPubMedGoogle Scholar
  21. 21.
    Carter, DR, Bouxsein, ML, Marcus, R 1992New approaches for interpreting projected bone densitometry data.J Bone Miner Res7137145PubMedGoogle Scholar
  22. 22.
    Martin, R, Burr, D 1984Non-invasive measurement of long bone cross-sectional moment of inertia by photon absorptiometry.J Biomech17195201Google Scholar
  23. 23.
    Beck, T, Looker, AC, Ruff, CB, Sievanen, H, Wahner, HW 2000Structural trends in the aging femoral neck and proximal shaft: analysis of Third National Health and Nutrtion Examination Survey dual-energy X-ray absorptiometry data.J Bone Miner Res1522972304PubMedGoogle Scholar
  24. 24.
    Rey, P, Sornay–Rendu, E, Garnero, P, Vey–Marty, B, Delmas, PD 1994Measurement of feorearm bone mineral density by X-ray absorptiometry: comparison with other skeletal sites.Rev Rhum Engl Ed61548554Google Scholar
  25. 25.
    Boivin, G, Meunier, PJ 2002The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography.Calcif Tissue Int70503511CrossRefPubMedGoogle Scholar
  26. 26.
    Lu, PW, Cowell, CT, Lloyd–Jones, SA, Briody, JN, Howman–Giles, R 1996Volumetric bone mineral density in normal subjects aged 5–27 years.J Clin Endocrinol Metab8115861590PubMedGoogle Scholar
  27. 27.
    Chatelais, PG, van Wyk, JJ, Copeland, KC, Blethen, SL, Underwood, LE 1983Effect of in vitro action of serum preoteases or exposure to acid on measurable immunoreactive somatomedin-C in serum.J Clin Endocrinol Metab56376383PubMedGoogle Scholar
  28. 28.
    Sassolas, G, Chatelain, P, Cohen, R, Boissel, JP, Laporte, S, Galleyrand, J, Claustrat, B, Elmcharfi, A, Cayvialle, JA, Cohen, H, Ferry, S, Underwood, L 1984Effects of human pancreatic tumor growth hormone-releasing (hpGRH1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men.J Clin Endocrinol Metab59705709PubMedGoogle Scholar
  29. 29.
    Juul, A, Dalgaard, P, Blum, WF, Bang, P, Hall, K, Michaelsen, KF, Müller, J, Skakkebaek, NE 1995Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.J Clin Endocrinol Metab8025342542PubMedGoogle Scholar
  30. 30.
    Paolisso, G, Ammendola, S, del Buono, A, Gambardella, A, Riondino, M, Tagliamonte, MR, Rizzo, MR, Carella, C, Varricchio, M 1997Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.J Clin Endocrinol Metab8222042209PubMedGoogle Scholar
  31. 31.
    Bremond, AG, Claustrat, B, Rudigoz, RC, Seffert, P, Corniau, J 1982Estradiol, androstenedione, and dehydroepiandrosterone sulfate in the ovarian and peripheral blood of postmenopausal patients with and without endometrial cancer.Gynecol Oncol14119124PubMedGoogle Scholar
  32. 32.
    Chapuy, MC, Preziosi, P, Maamer, M, Arnaud, S, Galan, P, Hercberg, S, Meunier, PJ 1997Prevalence of vitamin D insufficiency in an adult normal population.Osteoporos Int7439443CrossRefPubMedGoogle Scholar
  33. 33.
    Arvat, E, Gianotti, L, Grottoli, S, Imbimbo, BP, Lenaerts, V, Deghenghi, R, Camanni, F, Ghigo, E 1994Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.J Clin Endocrinol Metab7914401443PubMedGoogle Scholar
  34. 34.
    Ghigo, E, Goffi, S, Nicolosi, M, Arvat, E, Valente, F, Mazza, E, Ghigo, MC, Camanni, F 1990Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.J Clin Endocrinol Metab7114811485PubMedGoogle Scholar
  35. 35.
    Russell–Aulet, M, Jaffe, CA, Demott–Friberg, R, Barkan, AL 1999In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging.J Clin Endocrinol Metab8434903497PubMedGoogle Scholar
  36. 36.
    Alba–Roth, J, Müller, OA, Schopohl, J, von Werder, K 1988Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.J Clin Endocrinoi Metab6711861189Google Scholar
  37. 37.
    Russell–Aulet, M, Shapiro, B, Jaffe, CA, Gross, MD, Barkan, AL 1998Peak bone mass in young healthy men is correlated with the magnitude of endogenous growth hormone secretion.J Clin Endocrinol Metab8334633468Google Scholar
  38. 38.
    Rosen, T, Wilhelmsen, L, Landin–Wilhelmsen, K, Lappas, G, Bengtsson, BA 1997Increased fracture frequency in adult patients with hypopituitarism and GH deficiency.Eur J Endocrinol137240245PubMedGoogle Scholar
  39. 39.
    Wuster, C, Abs, R, Bengtsson, BA, Bennmarker, H, Feldt–Rasmussen, U, Hernberg–Stahl, E, Monson, JP, Westberg, B, Wilton, P 2001The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density.J Bone Miner Res16398405PubMedGoogle Scholar
  40. 40.
    Johansson, G, Rosén, T, Bosaeus, I, Sjöström, L, Bengtsson, BA 1996Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.J Clin Endocrinol Metab8128652873PubMedGoogle Scholar
  41. 41.
    Reed, BY, Zerwekh, JE, Sakhaee, K, Breslau, NA, Gottschalk, F, Pak, CYC 1995Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis.J Bone Miner Res1012181224Google Scholar
  42. 42.
    Välimäki, MJ, Salmela, PI, Salmi, J, Viikari, J, Kataja, M, Turunen, H, Soppi, E 1999Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults.Eur J Endocrinol140545554Google Scholar
  43. 43.
    Holmes, SJ, Whitehouse, RW, Swindell, R, Economou, G, Adams, JE, Shalet, SM 1995Effect of growth hormone replacement on bone mass in adults onset growth hormone deficiency.Clin Endocrinol42627633Google Scholar
  44. 44.
    ter Maaten, JC, de Boer, H, Kamp, O, Stuurman, L, van der Veen, EA 1999Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency.J Clin Endocrinol Metab8423732380PubMedGoogle Scholar
  45. 45.
    Biller, BMK, Sesmilo, G, Baum, HBA, Hayden, D, Schoenfeld, D, Klibanski, A 2000Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bon density and body composition in men with adult-onset GH deficiency.J Clin Endocrinol Metab85970976PubMedGoogle Scholar
  46. 46.
    Landin–Wilhelmsen, K, Nilsson, A, Bosaeus, I, Bengtsson, BA 2003Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial.J Bone Miner Res18393405PubMedGoogle Scholar
  47. 47.
    Rosen, CJ, Wüster, C 2003Growth hormone rising: did we quit too quickly?J Bone Miner Res18406409Google Scholar
  48. 48.
    Bravenboer, N, Holzman, P, de Boer, H, Roos, JC, van der Veen, EA, Lips, P 1997The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men.J Clin Endocrinol Metab8218181822PubMedGoogle Scholar
  49. 49.
    Toogood, AA, Adams, JE, O’Neill, PA, Shalet, SM 1997Elderly patients with adult-onset growth hormone deficiency are not osteopenic.J Clin Endocrinol Metab8214621466PubMedGoogle Scholar
  50. 50.
    Rudman, D, Feller, AG, Nagraj, HS, Gergans, GA, Lalitha, PY, Goldberg, AF, Schlenker, RA, Cohn, L, Rudman, IW, Mattson, DE 1990Effects of human growth hormone in men over 60 years old.N Engl J Med32316PubMedGoogle Scholar
  51. 51.
    Papadakis, MA, Grady, D, Black, D, Tierney, MJ, Gooding, GAW, Schambelan, M, Grunfeld, C 1996Growth hormone replacement in healthy older men improves body composition but not functional ability.Ann Intern Med124708716PubMedGoogle Scholar
  52. 52.
    Fernholm, R, Bramnert, M, Hägg, E, Hilding, A, Baylink, DJ, Mohan, S, Thorén, M 2000Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.J Clin Endocrinol Metab8541044112PubMedGoogle Scholar
  53. 53.
    Christmas, C, O’Connor, KG, Harman, SM, Tobin, JD, Münzer, T, Ballantoni, MF, Clair, CS, Pabst, KM, Sorkin, JD, Blackman, MR 2002Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men.J Gerontol A Biol Sci Med Sci57AM12M18Google Scholar
  54. 54.
    Thiébaud, D, Burckhardt, P, Costanza, M, Sloutskis, D, Gilliard, D, Quinodoz, F, Jacquet, AF, Burnand, B 1997Importance of albumin, 25(OH)-vitamin D and IGFBP-3 as risk factors in elderly women and men with hip fracture.Osteoporos Int7457462CrossRefPubMedGoogle Scholar
  55. 55.
    Ernst, M, Rodan, GA 1990Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3.Endocrinology127807814PubMedGoogle Scholar
  56. 56.
    Blum, WF, Albertsson–Wikland, K, Rosberg, S, Ranke, MB 1993Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion.J Clin Endocrinol Metab7616101616PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • P. Szulc
    • 1
  • M. O. Joly–Pharaboz
    • 2
  • F. Marchand
    • 3
  • P. D. Delmas
    • 1
  1. 1.INSERM 403 Research UnitHôpital Edouard Herriot, 69437 LyonFrance
  2. 2.Laboratoire de Biochimie EndocrinienneHôpital Edouard Herriot, 69437 LyonFrance
  3. 3.Société de Secours Minière de Bourgogne71300 Montceau les MinesFrance

Personalised recommendations